Clinical Trial Update: Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of FOLFIRI in patients 70 years and older with gastric cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)

Snippet

Sponsor: Institut Bergonié | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-09-16